pharmacogenomics to personalize drug therapy based on a person's genes

July 2005

See new information from the FDA regarding clearing a genetic lab test for warfarin sensitivity

You'll hear more about using pharmacogenomics to personalize drug therapy based on a person's genes.

Race is sometimes used to predict a person's response to a drug. This is based on the ASSUMPTION that members of a race share genetic similarities.

BiDil (isosorbide and hydralazine), for example, is now the first drug approved for a specific race...treating heart failure in African Americans.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote